Latest News about BMY
Recent news which mentions BMY
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
Amazon, Target And 3 Other Stocks Insiders Are Selling
September 19, 2022
From Benzinga
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Tickers
BMY
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
From Benzinga
AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday
September 19, 2022
From Benzinga
3 Stocks to Buy and Hold Forever
September 17, 2022
From Motley Fool
Why Ventyx Biosciences Zoomed Nearly 60% Higher This Week
September 16, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Bristol-Myers Squibb And 2 Other Stocks Insiders Are Selling
September 16, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Melanoma Study Achieves Key Milestone as Bristol's Flagship Treatment Secures Improvement in Survival Rates
September 15, 2022
Tickers
BMY
From Benzinga
These 5 Experts See A Market Crash Ahead: What Do BZ Readers Think?
September 14, 2022
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
September 14, 2022
From Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
From Benzinga
7 Screaming Buy Stock Picks to Beat the September Market Slump
September 13, 2022
From InvestorPlace
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
From Benzinga
NIO, Lucid Group And Other Big Gainers From Monday
September 13, 2022
From Benzinga
Why Clovis Oncology Zoomed 30% Higher Today
September 12, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
